MRP Gene Expression in Bladder Cancer
Author Information
Author(s): SC Clifford, DE Neal, J Lunec
Primary Institution: University of Newcastle-upon-Tyne
Hypothesis
The study investigates the expression levels of the MRP gene in high-grade transitional cell carcinoma of the bladder and its implications for chemotherapy resistance.
Conclusion
The study found that MRP mRNA levels are significantly reduced in a greater proportion of high-grade bladder tumors compared to low- and moderate-grade tumors.
Supporting Evidence
- MRP mRNA levels were significantly reduced in 55% of high-grade tumors compared to only 8% of low-grade tumors.
- All tumor samples analyzed showed detectable levels of MRP mRNA.
- MRP mRNA levels varied widely among individual tumors, with a 190-fold range observed.
Takeaway
This study looked at how a gene related to drug resistance behaves in bladder cancer, finding that more advanced tumors often have lower levels of this gene.
Methodology
The study used RT-PCR to quantify MRP mRNA levels in untreated TCC samples and compared them with normal bladder tissue.
Limitations
The study had a limited number of patients and did not find a consistent relationship between MRP levels and chemotherapy response.
Participant Demographics
The study included patients with high-grade transitional cell carcinoma of the bladder, primarily males aged 60-70.
Statistical Information
P-Value
0.018
Statistical Significance
p=0.018
Want to read the original?
Access the complete publication on the publisher's website